Paroxysmal nocturnal hemoglobinuria epidemiology and demographics: Difference between revisions
(→Race) |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Paroxysmal nocturnal hemoglobinuria}} | {{Paroxysmal nocturnal hemoglobinuria}} | ||
{{CMG}}; {{AE}} {{AEL}} | |||
==Overview== | ==Overview== | ||
Revision as of 18:36, 31 July 2018
|
Paroxysmal nocturnal hemoglobinuria Microchapters |
|
Differentiating Paroxysmal nocturnal hemoglobinuria from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Paroxysmal nocturnal hemoglobinuria epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Paroxysmal nocturnal hemoglobinuria epidemiology and demographics |
|
FDA on Paroxysmal nocturnal hemoglobinuria epidemiology and demographics |
|
CDC on Paroxysmal nocturnal hemoglobinuria epidemiology and demographics |
|
Paroxysmal nocturnal hemoglobinuria epidemiology and demographics in the news |
|
Blogs on Paroxysmal nocturnal hemoglobinuria epidemiology and demographics |
|
Directions to Hospitals Treating Paroxysmal nocturnal hemoglobinuria |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Elsaiey, MBBCH [2]
Overview
Epidemiology and Demographics
Incidence
- The incidence of paroxysmal nocturnal hemoglobinuria is approximately 0.13 per 100,000 individuals worldwide.
Age
- Paroxysmal nocturnal hemoglobinuria commonly affects adults. However, some cases of PNH in the childhood have been reported.[1]
Race
- There is no racial predilection to [disease name].
Gender
- Paroxysmal nocturnal hemoglobinuria affects men and women equally.
Region
- The majority of [disease name] cases are reported in [geographical region].
- [Disease name] is a common/rare disease that tends to affect [patient population 1] and [patient population 2].
Developed Countries
Developing Countries
References
- ↑ Curran KJ, Kernan NA, Prockop SE, Scaradavou A, Small TN, Kobos R; et al. (2012). "Paroxysmal nocturnal hemoglobinuria in pediatric patients". Pediatr Blood Cancer. 59 (3): 525–9. doi:10.1002/pbc.23410. PMID 22147651.